SHL Telemedicine Q2 and half year results reflect consistent and continued progress in line with plan. Financial guidance for the year confirmed.

Second Quarter highlights • Revenues of USD 12.0 million (USD 13.5 million at constant exchange rates*), representing a growth of 5.5% over Q2 09 at constant exchange rates*.• EBITDA of USD 2.8…

Continue ReadingSHL Telemedicine Q2 and half year results reflect consistent and continued progress in line with plan. Financial guidance for the year confirmed.
  • Post category:
  • Post comments:0 Comments

SHLTelemedicine in Q1 – Good financial results for Q1. Implementing expansion strategy with commencement of marketing activities in the German consumer market to be followed by entry to the UK.

• Revenues of USD 12.4 million (USD 13.2 million at constant exchange rates*),representing a growth of 9.1% at constant exchange rates* over first quarter of 2009 • EBITDA of USD 3.1 million…

Continue ReadingSHLTelemedicine in Q1 – Good financial results for Q1. Implementing expansion strategy with commencement of marketing activities in the German consumer market to be followed by entry to the UK.
  • Post category:
  • Post comments:0 Comments

SHL in 2009 with substantial growth and progress leading to significantly improved financial performance. Investing in new paths for growth.

Fiscal year 2009:• Revenues reaching USD 47.9 million (USD 51.0 million at constant exchange rates*).Representing growth of 14.4% year over year at constant exchange rates*.• EBITDA of USD 11.6 million…

Continue ReadingSHL in 2009 with substantial growth and progress leading to significantly improved financial performance. Investing in new paths for growth.
  • Post category:
  • Post comments:0 Comments